PHR 2500
Drg Disc,Dev,Deliv
3 cr
Provides a comprehensive overview of the drug discovery, development, and delivery process within the U.S. healthcare system, exploring the roles of vested stakeholders (e.g., patients, pharmaceutical industry, providers, insurers, society, etc.) during a drug's "bench to bedside" development including its post-development place in therapy.
Grade history
3,113 students across 7 instructors · course avg 3.71
1,189 students · 13 terms
1,189 students total · 13 terms · click to see per-term
482 students · 7 terms
482 students total · 7 terms · click to see per-term
Instructor unknown
3.78 GPAmedian 4.0470 students · 5 terms
470 students total · 5 terms · click to see per-term
431 students · 5 terms
431 students total · 5 terms · click to see per-term
404 students · 4 terms
404 students total · 4 terms · click to see per-term
116 students · 1 term
116 students total · 1 term · click to see per-term
21 students · 1 term
21 students total · 1 term · click to see per-term
Source: historical OSU grade releases via thegradeguide.com (Adam Gluck), Spring 2016 – Summer 2023. FERPA-filtered: sections under 10 students excluded.
Sections
4
Instructors
3
Enrolled
105 / 180
Open
4
Instructors
Sections in Autumn 2026
| # | Sec | Instructor | Hist. GPA | Days/Time | Room | Enrollment |
|---|---|---|---|---|---|---|
| 37991 | 0010 | Margie Neidecker, Nick Waltz | 3.69 GPA | TBA | Online | Open · 3/15 |
| 37613 | 0020 | Karl Andrew Werbovetz, Marje Winhoven | — | R 12:45 pm-2:05 pm | PK 250 250 | Open · 34/40 |
| 37614 | 0030 | Jenny Wei, Brenna Hepp | — | TBA | ONLINE | Open · 34/40 |
| 14537 | 10 | Margie Neidecker, Nick Waltz | 3.69 GPA | TBA | ONLINE | Open · 34/85 |